Evidence map›Paper›PMID 28910259›Full record

ArticleCanadian journal of public health = Revue canadienne de sante publique2017

Estimation of smoking prevalence in Canada: Implications of survey characteristics in the CCHS and CTUMS/CTADS.

Thierry Gagné

Abstract read
In one paragraph

Article in Canadian journal of public health = Revue canadienne de sante publique, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A cost-utility analysis of the impact of electronic nicotine delivery systems on health care costs and outcomes in Canada.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Thierry GagnéIRSPUM, 7101 av. du Parc, office 3139, Montréal, QC, H3N 1X9, Canada. thierry.gagne@umontreal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main enterprises associated with tobacco control is surveillance, that is, to measure and follow over time the extent of smoking among the Canadian population. While surveillance systems have been in place for more than 50 years, knowing the exact prevalence of smoking in Canada continues to be a complex matter and understanding its estimation requires a critical appreciation of our national surveys' idiosyncrasies. This commentary describes the two Statistics Canada surveys that are most commonly used to examine smoking prevalence in this country: the Canadian Community Health Survey (CCHS) and the Canadian Tobacco, Alcohol and Drugs Survey (CTADS). It compares estimates of smoking prevalence obtained from each source and examines potential reasons for their noticeable discrepancies. Canadian researchers interested in smoking prevalence should be aware of current and future limitations, and should discuss and analyze these accordingly.

Indexed as

Health SurveysCanadaHumansPopulation SurveillancePrevalenceReproducibility of ResultsSmoking

Identifiers

PMID28910259
PMCPMC6972049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.